Pedro-Antonio Regidor (P-A Regidor, P A Regidor, Pedro A Regidor, Pedro Antonio Regidor)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 26

Top Venues

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception

Women's health (London, England)

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

International journal of endocrinology

Exeltis

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Exeltis Jul 01 2013

Spain

Medical Director :: Medical

Publications

Kristina Biskupska-Bodova, Joanna Sójka-Kupny, Tamás Nyirády, Anne E Burke, Alicyoy Angulo, Pedro-Antonio Regidor
A randomised double-blind trial to determine the bleeding profile of the prolonged-release contraceptive dienogest 2 mg/ethinylestradiol 0.02 mg versus an immediate-release formulation of drospirenone 3 mg/ethinylestradiol 0.02 mg. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2024)
Ekkehard Schleußner, Susan Jäkel, Christoph Keck, Kirsten Kuhlmann, Mandy Mangler, Wolfgang E Paulus, Johanna Eiblwieser, Theresa Steeb, Pedro-Antonio Regidor
Nausea and Vomiting of Pregnancy and its Management with the Dual-Release Formulation of Doxylamine and Pyridoxine. Geburtshilfe und Frauenheilkunde 84 (2) (2024)
Pedro-Antonio Regidor, Enrico Colli, Artur Jakimiuk
The drospirenone only pill as a contraceptive option for breastfeeding women: First data on users' acceptability and newborn development. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 40 (1) (2024)
Pedro-Antonio Regidor, Anna Mueller, Manuela Mayr
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. Women's health (London, England) 19 (2023)
Ali Kubba, Kristina Gemzell-Danielsson, Santiago Palacios, Inka Wiegratz, Giovanni Grandi, Enrico Colli, Pedro-Antonio Regidor
The drospirenone (DRSP)-only pill: clinical implications in the daily use. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 28 (1) (2023)
Pedro-Antonio Regidor, Anna Mueller, Manuela Mayr
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. Women's health (London, England) 19 (2023)
Pedro-Antonio Regidor, Anna Mueller, Manuela Mayr
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. Women's health (London, England) 19 (2023)
Ali Kubba, Kristina Gemzell-Danielsson, Santiago Palacios, Inka Wiegratz, Giovanni Grandi, Enrico Colli, Pedro-Antonio Regidor
The drospirenone (DRSP)-only pill: clinical implications in the daily use. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 28 (1) (2023)
Pedro-Antonio Regidor, Santiago Palacios, Enrico Colli
Bleeding profile of women with cardiovascular risk factors using a drospirenone only pill with 4 mg over nine cycles compared to desogestrel 0.075 mg. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 38 (4) (2022)
Giuseppe M C Rosano, Maria Angeles Rodriguez-Martinez, Ilaria Spoletini, Pedro-Antonio Regidor
Obesity and contraceptive use: impact on cardiovascular risk. ESC heart failure (2022)
Pedro-Antonio Regidor, Enrico Colli
The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2022)
Pedro-Antonio Regidor, Xavier de la Rosa, Anna Müller, Manuela Mayr, Fernando Gonzalez Santos, Rafael Gracia Banzo, Jose Miguel Rizo
PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs). Biomedicines 10 (2) (2022)
Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor
Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 26 (6) (2021)
Johannes Huber, Anna Mueller, Manuela Sailer, Pedro-Antonio Regidor
Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Women's health (London, England) 17 (2021)
Pedro-Antonio Regidor, Enrico Colli, Santiago Palacios
Overall and bleeding-related discontinuation rates of a new oral contraceptive containing 4 mg drospirenone only in a 24/4 regimen and comparison to 0.075 mg desogestrel. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 37 (12) (2021)
Dace Melka, Kalev Kask, Enrico Colli, Pedro-Antonio Regidor
A single-arm study to evaluate the transfer of drospirenone to breast milk after reaching steady state, following oral administration of 4 mg drospirenone in healthy lactating female volunteers. Women's health (London, England) 16 (2021)
Pedro-Antonio Regidor, Anna Mueller, Manuela Sailer, Fernando Gonzalez Santos, Jose Miguel Rizo, Fernando Moreno Egea
Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. International journal of molecular sciences 22 (1) (2020)
Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor
Efficacy and cardiovascular safety of the new estrogen-free contraceptive pill containing 4 mg drospirenone alone in a 24/4 regime. BMC women's health 20 (1) (2020)
S Palacios, E Colli, Pedro-Antonio Regidor
Bleeding profile of women using a drospirenone-only pill 4 mg over nine cycles in comparison with desogestrel 0.075 mg. PloS one 15 (6) (2020)
Pedro-Antonio Regidor, Enrico Colli, Dimitar Georgiev, Rossen Koytchev, Wolfram Richter
Safety, influence on the endometrium, sonographic changes and bleeding profile after 13 cycles with the new drospirenone only pill (DOP) for contraception. Hormone molecular biology and clinical investigation 42 (2) (2020)
Santiago Palacios, Pedro-Antonio Regidor, Enrico Colli, Sven Olaf Skouby, Dan Apter, Thomas Roemer, Christian Egarter, Rossella E Nappi, Aleš Skřivánek, Artur J Jakimiuk, Steven Weyers, Nándor Ács, David Elia, Kristina Gemzell Danielsson, Johannes Bitzer
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 25 (3) (2020)
Manuela Sailer, Enrico Colli, Pedro-Antonio Regidor
In vitro evaluation of microbial adhesion to a contraceptive vaginal ring with a new polymer composition. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 24 (3) (2019)
P Hadji, E Colli, Pedro-Antonio Regidor
Bone health in estrogen-free contraception. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 30 (12) (2019)
Santiago Palacios, Enrico Colli, Pedro-Antonio Regidor
Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill. Acta obstetricia et gynecologica Scandinavica 98 (12) (2019)
Bernd Lesoine, Pedro-Antonio Regidor
Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality. International journal of endocrinology 2016 (2016)
Pedro-Antonio Regidor, Adolf Eduard Schindler
Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. International journal of endocrinology 2016 (2016)

Pedro-Antonio Regidor.css-eqlu8i{font-size:small;padding-left:4px;} (P-A Regidor, P A Regidor, Pedro A Regidor, Pedro Antonio Regidor)

Publication Activity (10 Years)

Top Topics

Top Venues

Pedro-Antonio Regidor (P-A Regidor, P A Regidor, Pedro A Regidor, Pedro Antonio Regidor)